DOG

(redirected from 2-Deoxy-D-glucose)
Also found in: Medical, Wikipedia.
AcronymDefinition
DOGDiario Oficial de Galicia (Official Bulletin for Galicia Spain)
DOGDeutsche Ophthalmologische Gesellschaft (Heidelberg, Germany)
DOGDepartment Of Geography
DOGDeutsche Olympische Gesellschaft (German Olympic Society)
DOGDifference of Gaussians (filter)
DOGDutch Oven Gathering
DOGDaily Oral Geography (education)
DOGDigitally Originated Graphic
DOGDog Opportunity Group (dog park proponents)
DOGDisciples of Gaming (gaming clan)
DOGDivision Officer's Guide
DOGDeath or Glory
DOGDepend on God
DOGDeployable Operations Group (USCG)
DOGDance Off Gracefully
DOGDetroiters Out to Get John Engler
DOGDigital Operations Guide
DOGDrop Out Generator
DOGDrop On Ground - Telephone
DoGDads of Gaming (forum)
DOGDelay of Gratification
DOG2-Deoxy-D-Glucose
DOGDelusions of Grandeur
DOGDepartment of Oil and Gas
DOGDigital Onscreen Graphic
DOGDaughters Of Godiva (interactive novel)
References in periodicals archive ?
Rajoka and Khan [37] isolated 2-deoxy-D-glucose and cycloheximide resistant mutant of Kluyveromyces marxianus PPY125 to study the production of [beta]-xylosidase in growth medium containing different carbon sources.
Das, Production of Glucoamylase by 2-deoxy-D-glucose Resistant Mutant of Aspergillus terreus, Biotech.
strains based on 2-deoxy-d-glucose resistance and physiological analysis, J.
2-Deoxy-D-glucose was used at 1 mg mL-l for selection of mutant derived strains having the potential of enhance production of glucose oxidase.
It is reported that 2-deoxy-D-glucose is one of the best agent to screen and isolate the mutants with increased glucose oxidase activity (Gromada and Fiedurek, 1997), glucoamylase (Fiedurek et al.
and Th1, Th2 and Th3 cytokines in the radiosensization of Ehrlich ascites tumor by the glycolytic inhibitor 2-deoxy-D-glucose (2-DG).
Heterogeneity in 2-deoxy-D-glucose induced modifications in energetic and radiation responses of human tumor cell lines.
Certain metabolic and pharmacologic effects in cancer patients given infusions of 2-deoxy-D-glucose.